The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
about
Fraction size in radiation therapy for breast conservation in early breast cancerPartial breast irradiation for early breast cancerModern Radiotherapy Concepts and the Impact of Radiation on Immune ActivationHypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgeryBreast Reconstruction after MastectomyEmerging Role of Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Modern Radiotherapy of Breast CancerHypofractionated whole breast radiotherapy: current perspectivesRadiotherapy of Ductal Carcinoma In SituRadiotherapy of the Lymphatic Pathways in Early Breast CancerAccelerated Partial Breast Irradiation in Clinical PracticeHypofractionated Radiotherapy as Adjuvant Treatment in Early Breast Cancer. A Review and Meta-Analysis of Randomized Controlled TrialsTreatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and BenefitsIntraoperative radiotherapy for breast cancer: the lasting effects of a fleeting treatmentDissecting the molecular mechanism of ionizing radiation-induced tissue damage in the feather follicleOptimal management of breast cancer in the elderly patient: current perspectivesAdjuvant treatment for older women with invasive breast cancerClinical trials in low and middle-income countries - Successes and challengesTailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Current role of modern radiotherapy techniques in the management of breast cancer[Good Prognosis! Breast Cancer Update 2016].Use of low-value radiotherapy practices in Canada: an analysis of provincial cancer registry data.[Breast-conserving surgery plus adjuvant radiotherapy better than mastectomy? : The 10-year survival data from the Netherlands].Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy : Results of a single, institutional, retrospective study.An effective deep-inspiration breath-hold radiotherapy technique for left-breast cancer: impact of post-mastectomy treatment, nodal coverage, and dose schedule on organs at risk.The potential role of three-dimensional surface imaging as a tool to evaluate aesthetic outcome after Breast Conserving Therapy (BCT)Hypofractionated radiotherapy for breast cancer acceleration of the START A treatment regime: intermediate tolerance and efficacyAGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014.Frontiers in radiotherapy for early-stage invasive breast cancer.Boost IORT in Breast Cancer: Body of Evidence.Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.Inflammatory biomarker C-reactive protein and radiotherapy-induced early adverse skin reactions in patients with breast cancer.How can we best respect patient autonomy in breast cancer treatment decisions?Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current EvidenceHighlights from the 14(th) St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer.Benefits, risks, and safety of external beam radiation therapy for breast cancer.DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases.Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 casesHypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: impact on late toxicityThe in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiationAcute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
P2860
Q26471067-2D08F395-C68C-42D4-942B-911F9D4FE908Q26471072-CB9C98D1-A48D-4F8C-AF8A-438FE9DAE8BAQ26744490-A5468959-A24F-4D1F-BB3D-556D9249DD94Q26745834-90CB3349-B1D8-4F77-B88C-E74A9EEF0383Q26770246-FF57A6CC-C996-415E-91A6-DFF59E86675EQ26774616-C7549E9A-E3CD-446A-A89F-BBDE49E404AEQ26775841-35EEFBE4-37F2-41C4-B874-585E29B803D8Q26776277-564F4701-678E-43C7-BD7E-54B655047B8AQ26776280-CE1C8E00-F849-499B-913B-0527CD63391BQ26776283-256F432D-C8ED-4658-A236-BCCDB33D7CA0Q26776288-7266F985-34B8-420D-8EA8-045A6BE03199Q26998991-DF3FAB8B-63B2-4C89-84ED-7B51F17AAAFAQ27014710-099D7DC8-47AF-48B6-821D-A830DF5F666FQ27321224-48138544-ABE8-4AE7-8A0F-A323AE2542B2Q27690879-D72E36C5-74E1-4E6E-9120-8F91E34C4F67Q28066744-1E02D258-E127-41B0-85F8-AAC9C55D21FEQ28074682-DA397CF1-C0A7-4FFC-8070-D9848A36EF76Q28085062-8AC0E6D6-5F9C-4E2B-B681-F445CA2FEED1Q28972351-70E46F09-B3D1-4641-AB6E-EB7C98263AA5Q30249775-4077F2EA-0B3E-4040-ADD8-A151B2B2D917Q31140437-915133C3-0781-4750-A172-E75D82DA47B6Q31168251-753AC659-C96E-49D6-9D68-C4E22F594907Q33603367-B25739E1-23CA-4152-8880-1F4B94757DDCQ33812235-A4866D5D-06F0-4BCE-9A6E-8D266E91571AQ33843735-DE6147BD-B533-46A4-8270-BC94FB9D1778Q33957583-2C64B1FE-0B7D-4007-889F-F3FD572D504BQ34042627-3A8B87BE-577A-4F72-9D66-B05CAFBF30BEQ34124291-D42A38FE-F4FF-4656-A135-3F07A3532ED4Q34203340-D8BDD051-ADB1-4832-B8F3-399828B88555Q34742937-11EE104E-FBC1-44D5-BF05-5C98F866474FQ34970929-17093B51-28ED-466F-87F0-6F04330A5DE7Q35127923-10EC2EF9-D34C-4D09-BB51-85D2686305FBQ35399580-D3D59DF1-4027-429A-BE2A-45152958CDFBQ35496344-6E4997C3-1CE0-4788-BA95-199AAC1733D8Q35565325-EF8C290F-AB8D-437E-B88E-020E3682379DQ35894515-FAF0791A-B0C9-4911-B4E1-C400A7D96637Q36010013-A7B5459E-E6DF-4079-BEFF-37AA7F90791DQ36010018-C3B2057D-619F-43B3-AA90-F18347A4E246Q36069982-2A67FB3B-7B70-4D57-803B-A1A52D3F8563Q36254925-09EBC70B-AA1B-466A-9229-C1E2B3AD9DF5
P2860
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The UK Standardisation of Brea ...... randomised controlled trials.
@en
The UK Standardisation of Breast Radiotherapy
@nl
type
label
The UK Standardisation of Brea ...... randomised controlled trials.
@en
The UK Standardisation of Breast Radiotherapy
@nl
prefLabel
The UK Standardisation of Brea ...... randomised controlled trials.
@en
The UK Standardisation of Breast Radiotherapy
@nl
P2093
P50
P1433
P1476
The UK Standardisation of Brea ...... o randomised controlled trials
@en
P2093
Brian J Magee
H Jane Dobbs
J Roger Owen
Jane Barrett
John A Dewar
John R Yarnold
Judith Mills
Karen Venables
Mark A Sydenham
Pat A Lawton
P304
P356
10.1016/S1470-2045(13)70386-3
P577
2013-09-19T00:00:00Z